Cargando…
Comparing the burden of illness in patients with alopecia areata vs atopic dermatitis in the US population from a payer perspective
BACKGROUND: Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss. AA frequently co-occurs with other inflammatory autoimmune conditions, presenting a significant clinical burden. OBJECTIVE: To compare the burden of illness, direct and indirect costs in adult patients...
Autores principales: | Fenske, D. Christian, Ding, Yuxin, Morrow, Paula, Smith, Sarah G, Silver, Monica K, Moynihan, Meghan, Manjelievskaia, Janna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387998/ https://www.ncbi.nlm.nih.gov/pubmed/36989453 http://dx.doi.org/10.18553/jmcp.2023.29.4.409 |
Ejemplares similares
-
Alopecia areata after dupilumab for atopic dermatitis
por: Mitchell, Krystal, et al.
Publicado: (2018) -
Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
por: Kageyama, Reiko, et al.
Publicado: (2021) -
Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021) -
Alopecia areata-like and psoriasis after dupilumab use for atopic dermatitis()()
por: Maiolini, Viviane Maria, et al.
Publicado: (2021) -
Overview of alopecia areata for managed care and payer stakeholders in the United States
por: King, Brett, et al.
Publicado: (2023)